Skip to content

Clinical trials

Active, not recruiting Carcinoma, Non-Small-Cell Lung trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Active, not recruiting Country / region: China Clear all

183 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20151
20164
20173
20186
20199
202018
202126
202233
202334
202430
202516
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting183

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca23
Sichuan Baili Pharmaceutical Co., Ltd.11
Janssen Research & Development, LLC8
Merck Sharp & Dohme LLC7
Hoffmann-La Roche6
Eli Lilly and Company5
Fudan University5
Novartis Pharmaceuticals5
Sun Yat-sen University5
Daiichi Sankyo4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung183
Lung Neoplasms21
Colorectal Neoplasms10
Neoplasms10
Melanoma9
Neoplasm Metastasis9
Carcinoma, Renal Cell8
Squamous Cell Carcinoma of Head and Neck8
Brain Neoplasms7
Stomach Neoplasms6

Trials

Showing 1 to 25 of 183. Each trial links to its page on Pharma Observatory.

83 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.